| Identification | Back Directory | [Name]
(+)-3R,5S-FLUVASTATIN SODIUM SALT | [CAS]
155229-75-7 | [Synonyms]
(+)-3R,5S-FLUVASTATIN SODIUM SALT
(+)-3R,5S-Fluvastatin-d6 sodiuM salt
(3R,5S,6E)-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid
6-Heptenoic acid, 7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-, (3R,5S,6E)- | [Molecular Formula]
C24H26FNO4 | [MDL Number]
MFCD08063390 | [MOL File]
155229-75-7.mol | [Molecular Weight]
411.47 |
| Chemical Properties | Back Directory | [Melting point ]
>150°C (dec.) | [Boiling point ]
681.8±55.0 °C(Predicted) | [density ]
1.23 | [storage temp. ]
-20°C Freezer | [solubility ]
DMSO, Methanol, Water | [form ]
Solid | [pka]
4.27±0.10(Predicted) | [color ]
Pale Yellow |
| Hazard Information | Back Directory | [Uses]
A synthetic HMG-CoA reductase inhibitor. Antilipemic.This compound contains residual sodium chloride which is quantified on the certificate of analysis. | [Definition]
ChEBI: (3R,5S)-fluvastatin is a (6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid diastereoisomer in which the stereocentres beta- and delta- to the carboxy group have R and S configuration, respectively. The drug fluvastatin is an equimolar mixture of this compound and its enantiomer. It is a (6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid and a statin (synthetic). It is a conjugate acid of a (3R,5S)-fluvastatin(1-). It is an enantiomer of a (3S,5R)-fluvastatin. |
|
|